State Street Corp Celldex Therapeutics, Inc. Transaction History

State Street Corp

  • $2.36 Trillion
  • Q1 2025

A detailed history of State Street Corp transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,806,359 shares of CLDX stock, worth $61.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,806,359
Previous 3,234,961 13.25%
Holding current value
$61.7 Million
Previous $81.7 Million 37.69%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$18.15 - $27.6 $7.78 Million - $11.8 Million
-428,602 Reduced 13.25%
2,806,359 $50.9 Million
Q4 2024

Feb 14, 2025
BUY
$23.31 - $32.4 $17.5 Million - $24.3 Million
749,805 Added 30.17%
3,234,961 $81.7 Million
Q3 2024

Nov 14, 2024
SELL
$32.06 - $44.56 $5.58 Million - $7.75 Million
-173,932 Reduced 6.54%
2,485,156 $84.4 Million
Q2 2024

Aug 14, 2024
SELL
$32.76 - $42.56 $10.5 Million - $13.6 Million
-320,663 Reduced 10.76%
2,659,088 $98.4 Million
Q1 2024

May 15, 2024
BUY
$35.22 - $51.88 $21.2 Million - $31.3 Million
602,425 Added 25.34%
2,979,751 $125 Million
Q4 2023

Feb 14, 2024
BUY
$22.61 - $40.65 $1.91 Million - $3.43 Million
84,475 Added 3.68%
2,377,326 $94.3 Million
Q3 2023

Nov 14, 2023
SELL
$25.45 - $37.46 $11.1 Million - $16.3 Million
-434,455 Reduced 15.93%
2,292,851 $63.1 Million
Q2 2023

Aug 14, 2023
BUY
$30.29 - $38.28 $12.9 Million - $16.3 Million
424,781 Added 18.45%
2,727,306 $92.5 Million
Q1 2023

May 15, 2023
BUY
$34.78 - $47.43 $385,049 - $525,097
11,071 Added 0.48%
2,302,525 $82.8 Million
Q4 2022

Feb 14, 2023
SELL
$27.78 - $45.38 $24.4 Million - $39.9 Million
-880,124 Reduced 27.75%
2,291,454 $102 Million
Q3 2022

Nov 15, 2022
SELL
$22.7 - $37.57 $1.3 Million - $2.15 Million
-57,274 Reduced 1.77%
3,171,578 $89.2 Million
Q2 2022

Aug 15, 2022
BUY
$20.5 - $37.33 $11.2 Million - $20.4 Million
546,124 Added 20.36%
3,228,852 $87.1 Million
Q1 2022

May 16, 2022
BUY
$27.64 - $39.32 $8.7 Million - $12.4 Million
314,688 Added 13.29%
2,682,728 $91.4 Million
Q4 2021

Feb 14, 2022
BUY
$35.68 - $56.27 $18.2 Million - $28.7 Million
510,922 Added 27.51%
2,368,040 $91.5 Million
Q3 2021

Nov 15, 2021
SELL
$28.95 - $55.99 $6.86 Million - $13.3 Million
-237,100 Reduced 11.32%
1,857,118 $100 Million
Q2 2021

Aug 16, 2021
BUY
$20.71 - $35.37 $4.5 Million - $7.68 Million
217,241 Added 11.57%
2,094,218 $70 Million
Q1 2021

May 17, 2021
BUY
$16.19 - $29.91 $1.08 Million - $2 Million
66,717 Added 3.69%
1,876,977 $38.7 Million
Q4 2020

Feb 16, 2021
BUY
$14.99 - $22.75 $26.8 Million - $40.6 Million
1,784,873 Added 7030.66%
1,810,260 $31.7 Million
Q3 2020

Nov 10, 2020
BUY
$9.65 - $15.19 $244,984 - $385,628
25,387 New
25,387 $376,000

Others Institutions Holding CLDX

# of Institutions
188
Shares Held
69.3M
Call Options Held
220K
Put Options Held
310K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.03B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email